Paul Kelly

President at EnZeta Immunotherapies.

Coral Gables, FL
Form D signer
EnZeta Immunotherapies

Raised on EnZeta Immunotherapies filings

$840K

of $2.4M offered across 1 Form D filing

Form D filings: 1
Teammates: 1
Last filing: Mar 6, 2026

Company

EnZeta Immunotherapies

Biotech · Coral Gables, FL

Engineered T-cell therapies for solid tumors

Engineered T-cell therapies for solid tumors

Investors: 10
Founded: 2023
Still open: $1.5M

Investors: 10
Sector: Biotech
Founded: 2023
HQ: Coral Gables, FL

EnZeta Immunotherapies filings

EnZeta Immunotherapies Form D filings
Filed	Security	Sold of offered	Filing
Mar 6, 2026	Equity	$840K/ $2.4M	Form D/A

EquityFiled Mar 6, 2026Form D/A
$840K/ $2.4M

Works with

Also named on EnZeta Immunotherapies filings

Sergio TraversaDirector